Home
 
 

Drug Stores Industry

Hot Stocks in This Industry Not Available
Sector Drugs
Related Industries Drug Delivery, Drug Manufacturers - Major, Drug Manufacturers - Other, Drug Related Products, Drugs - Generic, Drugs Wholesale.
View all Industries

Stocks in Drug Stores

CVS
 

Drug Stores Upgrades

Date Ticker Analyst Old Rating New Rating
09/29/2009 WAG Barrington Research Market Perform Outperform
08/27/2009 WAG Raymond James Market Perform Outperform
08/05/2009 CVS William Blair Market Perform Outperform
01/16/2009 OCR Barclays Capital Equal Weight Overweight

Drug Stores Downgrades

Date Ticker Analyst Old Rating New Rating
11/06/2009 CVS William Blair Outperform Market Perform
09/25/2009 MHS Argus Buy Hold
09/22/2009 RAD Raymond James Outperform Market Perform
09/17/2009 MHS Goldman Sachs resumes coverage on Express Scripts Inc. (Nasdaq: Buy Neutral

Drug Stores New Coverages

Date Ticker Analyst Rating
09/18/2009 WAG FTN Equity Buy
06/12/2009 WAG First Global Market Perform
04/13/2009 WAG Gabelli & Co Buy
01/22/2009 PMC Credit Suisse Neutral

Drug Stores Earnings

Date Ticker Actual Expected Prev Yr Qtr
09/29/2009 WAG 0.44 0.39 0.45
09/24/2009 RAD -0.14 -0.16 -0.27
08/24/2009 NPD 0.04 0.04 0.08
08/04/2009 CVS 0.65 0.64 0.60
View more earnings releases

Drug Stores Hot Stock Quote

Special Offers

Buy stock for just $4
www.sharebuilder.com

Make the most of Volatility. Stream a free Webcast from The Options Industry Council.
optionseducation.org

Forex trading: Trade with the worldwide leader and most competitive broker!
www.ac-markets.com

Stock of the Day

The Drug Stores Industry's CVS Caremark (CVS) was InvestorGuide.com's Stock of the Day on 11/5/2009.
CVS is Pained by its Weak Pharmacy Benefits Division
CVS Caremark Corp. is a company that wears many different hats. The company runs a network of over 7,000 CVS drugstores, maintains pharmacy locations within those drugstores, and now also owns a pharmacy benefits company (Caremark). Although these businesses are very closely related, the acquisition of Caremark was questioned by many investors. Investors saw this as a risky move which might help the company, but one which might also cause more pain than it was worth. This quarter, as it has been with every quarter since the acquisition, investors and analysts waited to see if the results would help them determine if this was indeed a good decision or not. And based on the response of the investors after the earnings announcement, they got a very clear answer. Read more

Click here to see the complete Stock of the Day archives!

Subscribe to our Stock
of the Day Newsletter


 
 
Got feedback?
White Spacer
The market in:
: :
White Spacer
White Spacer